TrialInternational journal of clinical oncology2022

Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.

Takashi Kasai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.